Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America as represented by the Department of Veteran Affairs”

22 pharma patents match "The United States of America as represented by the Department of Veteran Affairs" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 22
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 22 pharmaceutical patents matching "The United States of America as represented by the Department of Veteran Affairs" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

22 results for “The United States of America as represented by the Department of Veteran Affairs” · 30,257 patents in full index Clear search

  1. US 10683363

    Targeting intracellular target-binding determinants with intracellular antibodies

    The United States of America as represented by the Department of Veteran Affairs · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  2. US 10335365

    Bladder cancer specific ligand peptides

    The United States of America as represented by the Department of Veteran Affairs (Washington DC) · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  3. US 10322125

    TGF-beta enhancing compositions for cartilage repair and methods related thereto

    The United States of America as represented by the Department of Veteran Affairs · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  4. US 10166244

    Targeting NCCA-ATP channel for organ protection following ischemic episode

    The United States of America as represented by the Department of Veteran Affairs · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  5. US 9801865

    Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  6. US 9789162

    Systemic and local ex vivo gene therapy of the skeleton

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  7. US 9598441

    Therapeutic compounds and methods

    The United States of America as represented by the Department of Veteran Affairs · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  8. US 9546151

    VMAT inhibitory compounds

    The United States of America as represented by the Department of Veteran Affairs · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted

  9. US 9458215

    Compositions and methods for osteogenic gene therapy

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  10. US 9173917

    Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug

    The United States of America as represented by the Department of Veteran Affairs · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  11. US 8961989

    Methods for producing an immune response to tuberculosis

    The United States of America as represented by the Department of Veteran Affairs · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  12. US 8895018

    Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

    The United States of America as represented by the Department of Veteran Affairs · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted

  13. US 8858930

    Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  14. US 8802835

    Proteins with repetitive bacterial-Ig-like (Big) domains present in leptospira species

    The United States of America as represented by the Department of Veteran Affairs · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

  15. US 8569377

    Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  16. US 8440206

    Methods for producing an immune response to tuberculosis

    The United States of America as represented by the Department of Veteran Affairs · Granted May 14, 2013 · Expires May 9, 2033

    granted

  17. US 8153156

    Hydrogel nanocompsites for ophthalmic applications

    The United States of America as represented by the Department of Veteran Affairs · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted

  18. US 8021671

    Pro-apoptotic bacterial vaccines to enhance cellular immune responses

    The United States of America as represented by the Department of Veteran Affairs · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  19. US 7173007

    Therapy for microbial infections

    The United States of America as represented by the Department of Veteran Affairs · Granted Feb 6, 2007 · Expires Feb 1, 2027

    granted

  20. US 6897227

    Prodrugs of proton pump inhibitors

    The United States of America as represented by the Department of Veteran Affairs · Granted May 24, 2005 · Expires May 19, 2025

    expired

  21. US 6559167

    Prodrugs of proton pump inhibitors

    The United States of America as represented by the Department of Veteran Affairs · Granted May 6, 2003 · Expires May 1, 2023

    expired

  22. US 6552006

    Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen

    The United States of America as represented by the Department of Veteran Affairs · Granted Apr 22, 2003 · Expires Apr 17, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.